T1	TimeInfo 0 6	1 Jahr
T2	Medication 44 46	IS
T3	Medication 51 54	CyA
T4	Condition 61 64	BKV
T5	Medication 75 78	MMF
T6	Medication 94 98	mTOR
T7	LabValues 103 107	Krea
T8	Measure 108 115	Anstieg
T9	LabValues 125 128	DSA
T10	LabValues 135 139	Krea
T11	Measure 140 159	sukzessive steigend
T12	Condition 161 163	GE
T13	Measure 164 170	unklar
T14	LabValues 172 174	PU
T15	Measure 179 184	1,4 g
R1	has_Measure arg1:T7 arg2:T8
R2	has_Measure arg1:T10 arg2:T11
R3	has_Measure arg1:T12 arg2:T13
R4	has_Measure arg1:T14 arg2:T15
T16	Tx_middle 0 14	1 Jahr nach TX
T17	Condition 16 26	Borderline
A1	Risk T17 increase_risk_factor
T18	TimeInfo 27 36	Frühphase
R5	has_TimeInfo arg1:T17 arg2:T18	
A2	Risk T2 decrease_risk_factor
A3	Risk T3 increase_risk_factor
A4	Risk T4 increase_risk_factor
T19	Measure 65 74	Reduktion
R6	has_Measure arg1:T5 arg2:T19	
A5	Risk T5 increase_risk_factor
T20	Temporal 0 14	1 Jahr nach TX
A6	Temporal_Element T20 present
T21	Temporal 16 36	Borderline Frühphase
A7	Temporal_Element T21 past
T22	Temporal 37 78;79 115	triple IS mit CyA, nach BKV Reduktion MMF Umstellung auf mTOR bei Krea Anstieg
A8	Temporal_Element T22 past_present
A9	Risk T6 increase_risk_factor
A10	Risk T7 increase_symptom
A11	Risk T9 increase_risk_factor
A12	Risk T10 increase_symptom
A13	Risk T14 increase_symptom
T23	Temporal 116 134	Nachweis DSA (neu)
A14	Temporal_Element T23 present
T24	Temporal 135 160	Krea sukzessive steigend,
A15	Temporal_Element T24 past_present
A16	Factuality T12 speculated
T25	Temporal 172 184	PU bei 1,4 g
A17	Temporal_Element T25 present
A18	Risk T16 risk_factor
T26	Measure 37 43	triple
R7	has_Measure arg1:T3 arg2:T26	
